Our paper on first ever reported establishment of a cell culture from a rare brain tumor (DIG glioma), is published in Frontiers in Pharmacology journal, with Impact factor of 4.5. Such primary cultures are very useful for drugdevelopment and phenotypic screening.
You might also like
Sree Voleti of BioNest and UoH in a wide-ranging frank monsoon chat with Jugnu on why she chose to return to India, why an entrepreneur, why Sapien, why Apollo, why Hyderabad …. on the road less travelled
Apollo Hospitals set to integrate clinical genomics as part of its personalized medicine initiatives
Sapien’s samples and real world data enables validation of a new Indian breast cancer test with high concordance to OncotypeDx test
Lymphomas are cancers that develop in the lymphatic system. Typical symptoms start with fever, swelling of some lymph nodes, weight loss, tiredness. The affected lymph nodes could be in the neck, armpit, groin, tonsils, stomach, small intestine. Once a cancer begins in one part of the lymphatic system, it can spread rapidly to other lymph nodes so early diagnosis is important. Diagnosis is done by PET or CT scan and/or biopsy, as suggested by a doctor. The incidence of lymphomas is ~5-7% among all childhood cancers. It is 2-3 time more common in boys than in girls. In India, lymphoma was reported to be the 2nd most common cancer in young boys.
Kidney cancer rarely affects children. The most common one is Wilms’ tumor, also called nephroblastoma, that accounts for up to 95% of childhood kidney cancers, with most children being below the age of 5 years. It is a fast growing tumor that can spread (metastasize). It is usually treated by surgery, followed by radiation and chemotherapy. Commonly used chemo drugs are doxorubicin, vincristine and actinomycin D. Overall survival rates tend to be high (>90%), with favourable histopathology diagnosis and timely treatment.
1st Floor, AIMSR Building,
Apollo Health City,
Hyderabad 500 096
- Our paper is out in Frontiers in Pharmacology
- Sapien’s work for Hillstream BioPharma presented at AACR
- Dr. Jugnu Jain shares her thoughts on entrepreneurship with the T-Hub Hyderabad
- Landscape of Kinase gene fusions in cancers
- ALK targeted therapy for lung cancer: Integration of NGS genome profiling in management of ALK-mutated NSCLCs in India